Soluble CD40 Ligand as a Promising Biomarker in Cancer Diagnosis
Alireza Pazoki(Semnan University of Medical Sciences), Valentyn Oksenych(University of Bergen), Dariush Haghmorad(Semnan University of Medical Sciences), Alireza Shadab(Iran University of Medical Sciences), Sepehr Dadfar(Semnan University of Medical Sciences)
Cited by 8
Related Papers
Divergent functions of NLRP3 inflammasomes in cancer: a review
|Cell Communication and Signaling|2023|76
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48